Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
The EU wants to be able to protect itself, alone, from a potential attack from 2030, but defence SMEs have faced challenges ...
A pair of marine scientists at the University of Antwerp, in Belgium, working with a colleague from the University of Otago, ...
Successful initial administration and full enrollment in first-in-human LIBERATE-1â„¢ study of NPM-115 (exenatide implant) in ...
Driven by escalating water concerns, the point-of-use water treatment systems market is rapidly growing, as consumers ...
Coronary artery disease has long been understood through the paradigm of epicardial coronary artery obstruction, causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results